About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

CAre of Patients With PArenteral Nutrition At Home | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01545063

CAre of Patients With PArenteral Nutrition At Home

This research aims to give an overview of a number of aspects related to the quality of care for adult patients on home parenteral nutrition. Concretely this study follows up different aspects on dif...

Lead sponsor: KU Leuven•13 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

KU Leuven

Collaborators

Ziekenhuis Netwerk Antwerpen (ZNA)
AZ Sint-Lucas Brugge
Universiteit Antwerpen
AZ Sint-Blasius Dendermonde
Imelda Hospital, Bonheiden
Ziekenhuis Oost-Limburg
AZ Damiaan, Oostende
H.-Hartziekenhuis Roeselare-Menen vzw
Universitair Ziekenhuis Brussel
University Hospital, Ghent
Jessa Hospital

Adult patients on HPN will be contacted by phone at three different time moments after their discharge to ask them about indicators, quality of life and discrepancies in medication use. After the follow-up, medical dossiers will be consulted to know which indicators are followed in practice. The role of the different health care providers will be investigated by face-to-face interviews with different healthcare professionals.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients in Flanders who speak Dutch, are older then 18 years and are able to give an informed consent.

Exclusion Criteria

•Patients who are younger then 18 years.

Related studies

RECRUITINGPhase 3

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

NCT07184931 · Crohn's Disease

RECRUITINGPhase 3

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

NCT06100289 · Ulcerative Colitis, Crohn's Disease

RECRUITINGPhase 3

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more

RECRUITINGPhase 4

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

NCT06180382 · Crohn's Disease

Real-World Study of IL-23 Inhibitors in Active Crohn's Disease

NCT07545317 · Crohn's Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 19, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment39

Start dateMay 2012

Last updatedJul 19, 2017

Condition

Crohn's Disease Peritoneal Carcinomatosis With Intestinal Occlusion Radiation Enteritis Chronic Diarrhea Intestinal Lymphomas

Locations shown

Antwerpen Middelheim

Antwerp

UZA Antwerpen Edegem

Antwerp

Imelda Ziekenhuizen Bonheide

Bonheiden

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 19, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions